1181891

SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals) — FEI 3004835618

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 20, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Dresden (Germany)